About share
Background
SHARE Paper 9. Conceptual perspective |
▪ Terminology and concepts – Health technologies – Disinvestment – Resource allocation – Optimising health care – Reinvestment ▪ Motivation and purpose – Impetus for disinvestment – Rationale for disinvestment ▪ Relationships with other healthcare improvement paradigms – Evidence based health care – Quality improvement – System redesign – Health economic approaches ▪ Challenges ▪ New approach to disinvestment |
SHARE Paper 10. Operational perspective |
▪ Existing theories, frameworks and models ▪ New framework ▪ Program – Principles of decision-making – Settings and opportunities – Prompts and triggers – Steps in the disinvestment process ▪ Projects ▪ Research ▪ Methods and tools – Identification of opportunities – Prioritisation and Decision-making – Development of a proposal – Implementation – Monitoring, Evaluation and Reporting – Reinvestment – Dissemination and Diffusion – Maintenance ▪ Barriers and enablers |
Aims
Existing theories, frameworks and models
Theories
Theory | Purpose | Context |
---|---|---|
Decision-making theory | To guide resource allocation decisions | Health service delivery organisations [16] |
Deliberative democratic theory Deliberation theory | To capture stakeholder perspectives | Pathology testing for vitamin B12 and folate [15] |
To underpin patient involvement | Priority setting healthcare improvement [13] | |
Social constructionist theory | To inform data analysis | Pathology testing for vitamin B12 and folate [15] |
Resource allocation theory | To refine arguments in funding debate | Assisted Reproductive Technologies [14] |
Prioritisation and quality improvement theories | To develop a proposal for rationalisation, prioritisation and rationing | Assisted Reproductive Technologies [17] |
Frameworks
Framework/Model | Setting | Aims | Method of development | Components |
---|---|---|---|---|
PROJECTS TO IDENTIFY AND DISINVEST INDIVIDUAL TCPS | ||||
Framework of potential settings and methods for disinvestment [5] | Organisation-wide program in local health service network | To identify potential settings and methods for disinvestment decision-making within local health service systems and processes | Literature review; survey of external experts, interviews and workshops with local stakeholders | Three organisational contexts that provide potential opportunities to introduce disinvestment decisions into health service systems and processes are presented in order of complexity, time to achieve outcomes and resources required: 1. Explicit consideration of potential disinvestment in routine decision-making for purchasing and procurement and development of guidelines and protocols, 2. Proactive decision-making about disinvestment driven by available evidence from published research and local data, 3. Specific exercises in priority setting and system redesign. |
Algorithm for selecting a disinvestment project from a catalogue of potential opportunities [9] | Organisation-wide program in local health service network | To facilitate decision-making for identification of potential and selection of actual disinvestment projects | Literature reviews; surveys, interviews and workshops with local stakeholders; document analysis; consultation with experts; taxonomy development | Five steps in selection process: 1. Assess highest risk, 2. Assess importance and potential, 3. Assess quality and strength of evidence, 4. Assess extent of problem, 5. Assess implications of change. Three key decision-making steps between Steps 2 and 3, 3 and 4, and after 5. After selection: Notify decision; Implement; Evaluate; Report Each step includes the activities, who will undertake them, and the decision options |
Model for an Evidence Dissemination Service [11] | Organisation-wide program in local health service network | To facilitate use of recently published synthesised evidence in organisational decision-making | Literature reviews; surveys, interviews and workshops with local stakeholders; document analysis; consultation with experts; taxonomy development | Methods and tools to identify sources of high quality synthesised evidence; automate methods of capture; classify, collate and store materials in useful categories; prioritise based on user and health service needs; repackage into suitable formats based on user needs; identify relevant individuals or groups to receive information; disseminate to the appropriate target groups, and report use of evidence |
Guideline for Not Funding Health Technologies (GuNFT) [35] | Two versions are provided, one for application at national and regional level and the other at local level. | To facilitate establishment of a transparent, systematic and explicit process for assessing the potential for disinvestment in certain health technologies or in some of their indications | Literature review; face-to-face meeting, teleconference and emails using Nominal Group Technique with 10 experts representing health care delivery, administration, technology assessment and consumers to draft the guideline; validation by two external experts in HTA; wide circulation for comment and approval | Seven phases: 1. Identification through applications; 2. Validation of applications; 3. Prioritisation (if necessary); 4. Assessment; 5. Decision making; 6. Development of an action plan; 7. Diffusion of the decision, the reasons why it has been taken and the action plan. Applications are submitted by health care professionals; validation, prioritisation and assessment of the applications are undertaken by a HTA agency or the health service Technology Assessment Committee; and the decision, development of the action plan and diffusion is undertaken by the health service or regional health authority management team or other multidisciplinary body. Tools are available. |
Disinvestment framework to guide resource allocation decisions in health service delivery [16] | Health service delivery organisations | To aid disinvestment activity in the local setting. | Thematic analysis of systematic review and a scoping review of the public sector and business literatures. Draft framework critiqued by Decision Maker Advisory Committee (Chief Financial Officers from Canadian health services) and External Reference Group (international academics) before being finalised. | Seven steps: 1. Determine objectives and scope; 2. Identify strategic priorities; 3. Identify options and risk; 4. Rank options; 5. Develop implementation plan; 6. Conduct disinvestment; 7. Assess outcomes and processes. Oversight Committee (senior managers and clinical leaders) is responsible for the majority of the process components including making final decisions; independent Assessment Committee (managers, clinicians, other staff and public representatives) defines the criteria, weights and scale used to assess disinvestment options, Support Committee (researchers and financial personnel) assists in the assessment of disinvestment options in the form of evidence, financial analysis and evaluative measures. |
PROGRAMS FOR SECTOR-WIDE INVESTMENT AND DISINVESTMENT | ||||
Framework of components in the resource allocation process [6] | Organisation-wide program in local health service network | To represent components in the process of resource allocation and the relationships between them | Interviews and workshops with stakeholders, thematic analysis of responses, document analysis, use of existing frameworks to synthesise findings | Eight components: Governance, Administration, Stakeholder engagement, Resources Decision Making, Implementation, Evaluation, and, when appropriate, Reinvestment. Details of elements of structure and practice within each component is provided. Structure is described as ‘who’ and ‘what’ and includes people, systems, policies, requirements, relationships and coordination. Practice addresses ‘how’ through processes, procedures, rules, methods, criteria and customs. |
Model for Sustainability in Health care by Allocating Resources Effectively (SHARE) [8] | Organisation-wide program in local health service network | To develop, implement and evaluate organisation-wide systematic, transparent, accountable and evidence-based decision-making systems and processes | Three literature reviews; online survey, interviews and structured workshops with stakeholders; consultation with experts in disinvestment, health economics and health program evaluation; drafted in consultation with staff, consumers and external experts; assessed against framework for success and sustainability | Four components, each with multiple elements: 1. Systems and processes; 2. Disinvestment projects; 3. Support services; 4. Program evaluation and research. The model outlines each component and the relationships between them, their aims and activities as well as the underlying principles and the preconditions required for success and sustainability. There is also detailed discussion of the antecedents, barriers and enablers. |
New Zealand National Health Committee Workplan [36] | National government decision-making | To provide the Minister of Health with recommendations for use and funding of health technologies | Not documented | The program addresses which technologies should be publicly funded, to what level and where technology should be provided and how new technology should be introduced and old technology removed. Six phases: 1. Identification, 2. Prioritisation, 3. Analyse and Assess, 4. Recommend, 5. Implement, 6. Evaluate. |
Health technology reassessment and decommissioning framework/model [37] | National or provincial government decision-making | To create a model for assessing the health technology life cycle to identify and delist obsolete technologies | Focused narrative literature review and input from experts. | Two components: 1. Health technology life cycle and reassessment, 2. Reassessment and Decommissioning Model, with Oversight Committee, Triggers, and Possible Outcomes. Second component includes triggers and processes, structure (oversight committee), decisions and outcomes |
PROGRAM EVALUATION | ||||
Framework for evaluation of priority setting [39] | National, regional and individual healthcare facilities | To develop a framework for the evaluation of priority setting practice at macro and meso levels | Literature review and thematic analysis | Two evaluation domains: 1. Consequentialist outcomes: Efficiency, Equity, Stakeholder satisfaction, Stakeholder understanding, Shifted (reallocation of resources), Implementation of decisions, 2. Proceduralist conditions: Stakeholder engagement, Empowerment, Transparency, Revisions, Use of evidence, Enforcement, Community values |
SHARE Program Evaluation Framework and Plan [8] | Organisation-wide program in local health service network | To assess the effectiveness of the SHARE program, implementation fidelity and factors for successful change | Drafts prepared by project team in consultation with Consultant in Health Program Evaluation to meet the information needs of key stakeholders and the internal capacity of staff conducting the project; revised and finalised in consultation with key stakeholders | Seven evaluation domains: 1. Improved patient care, 2. Improved resource allocation for health technologies and clinical practices, 3. Improved decision-making, 4. Improved staff capacity in use of evidence and data in decision-making and implementation of practice change, 5. Barriers and enablers, 6. Implementation fidelity, 7. Sustainability and spread. Includes an outcomes hierarchy based on the SHARE program components and a research program based on a theoretical framework for implementation of an evidence-based innovation. |
Framework for evaluation and explication of the processes and outcomes of a disinvestment project [9] | Organisation-wide program in local health service network | To adapt a framework and taxonomy for evaluation of evidence-based innovations to enable evaluation and explication of disinvestment projects | Literature review, surveys and interviews with stakeholders | Three components: 1. Determinants of effectiveness (characteristics of external environment, organisation, proposal for change, rationale and motivation, potential adopters, potential patients, identification process, prioritisation and decision-making process, implementation plan, implementation resources); 2. Process of change (delivery of implementation strategy and stages of change); 3. Outcomes (process and impact for patient, practitioner, systems, economic, reinvestment, sustainability and spread). Taxonomy containing details within each component is provided. |
Integrative framework for measuring overuse [38] | Relevant settings within health care systems | To assess the impact of efforts to reduce low-value care. | Not documented | Provides list of measurement tools linked to specific project/program goals and discusses advantages and disadvantages of each approach |
STAKEHOLDER ENGAGEMENT | ||||
SHARE model for incorporating consumer views into decisions for resource allocation [7] | Organisation-wide program in local health service network | To involve consumers in organisation-wide decision-making, capture their perspectives and incorporate them into decisions for resource allocation. | Literature review, individual and group interviews with Consumer Working Group and health service staff, workshop with Community Advisory Committee, drafting and revision with consumer participation. | Four components: 1. Principles, 2. Scope, 3. Preconditions, 4. Activities Activities include Consumer engagement (communication, consultation and participation) and use of Consumer evidence (consumer perspectives found in publications and data sources). Details of activities are reported in the context of the components of the resource allocation process noted above |
New Zealand National Health Committee Workplan [36] | National government decision-making | To seek advice and engage with the health sector | Not documented | Tiered approach to engage with and seek advice from clinicians via colleges and specialty societies; providers such as District Health Boards, NGOs and private facilities via Health Sector Forum; international Health Technology Assessment agencies; Universities and Research Institutes, international and domestic manufacturers. |
Models
New Framework
Audience
Application
Definitions
Health technologies | Health products, devices and equipment used to deliver health care (eg prostheses, implantable devices, vaccines, pharmaceuticals, surgical instruments, telehealth, interactive IT and diagnostic tools). This is a narrow definition which reflects the common use by decision-makers and consumers in the local health care setting. Clinical practices, support systems, or organisational and managerial systems are NOT considered to be health technologies in this context. |
Health technologies and clinical practices (TCPs) | Therapeutic, preventative and diagnostic procedures (eg use of products, devices and equipment PLUS medical, surgical, nursing, allied health and population health interventions). This is a pragmatic term to reflect the scope of most resource allocation decisions in the local healthcare setting. |
Health programs and services | Agencies, facilities, institutions and the components within them that deliver health care, rehabilitation or population health practices such as health promotion and education. |
Disinvestment | Removal, reduction or restriction of any aspect of the health system for any reason. Removal indicates complete cessation, reduction is a decrease in current volume or delivery sites, and restriction is narrowing of current indications or eligible populations. This is a broad definition, in essence the conceptual opposite of investment. This could apply equally to products, devices and equipment; clinical practices and procedures; health services and programs; information technology and corporate systems. |
Principles | Fundamental qualities or elements that represent what is desirable or essential in a system. |
Criteria | Standards against which alternatives can be judged in decision-making. |
Routine decisions | Decisions made on a recurring basis or scheduled via a timetable eg annual budget setting processes, six-monthly practice audits, monthly Therapeutics Committee meetings, reviews of protocols at specified intervals after their introduction, etc. |
Reactive decisions | Decisions made in response to situations as they arise eg new legislation, product alerts and recalls, applications for new drugs to be included in the formulary, critical incidents, emerging problems, etc. |
Proactive decisions | Decisions driven by information that was actively sought for the purpose of healthcare improvement eg accessing newly published synthesised research evidence such as Cochrane reviews or Health Technology Assessments to compare against current practice, interrogating routinely-collected datasets to ascertain practices with high costs or high rates of adverse events, etc. |
Prompt | An informal reminder or encouragement for thought or action. |
Trigger | A formal mechanism that initiates or activates a reaction, process or chain of events. |
Diffusion | Passive processes by which an innovation is communicated over time among members of a social system; usually unplanned, informal, untargeted, uncontrolled, decentralised, and largely horizontal or mediated by peers. |
Dissemination | Active processes to spread knowledge or research eg publications, presentations and other deliberate strategies; planned, formal, often targeted, controlled or centralised, and likely to occur more through vertical hierarchies. |
Maintenance | Active processes to sustain recently implemented change after project support is removed; to integrate the change into organisational systems, processes and practices; and to attain long-term viability of the change. |
Methods and tools | Approaches, instruments or other resources that identify ‘what’ tasks are needed at each step and/or ‘how’ to undertake them. This is a pragmatic inclusive definition developed for use in this review to assist health service staff in disinvestment. This broad definition allows frameworks and models to be included if they meet these criteria. |
Concepts
Concept | Implication for framework |
---|---|
Use of the term disinvestment as a driver or justification for change is associated with negative connotations such as focusing on cost cutting, engendering suspicion and distrust, and getting stakeholders offside. | Do not use ‘disinvestment’ as the basis for the framework or the aim of change initiatives |
Conducting disinvestment activities independently of existing systems and processes does not represent the reality of health service decision-making. It may be counterproductive: lacking incentives for change and introducing disincentives. Disinvestment should not be considered as an isolated activity, but integrated within existing systems and processes in the context of all resource allocation decisions, covering the spectrum from investment to disinvestment. | Implement disinvestment activities in the context of ‘resource allocation’ |
Removal or restriction of practices that are harmful or of little or no value; replacement of inferior practices with more effective or cost-effective alternatives; and reduction of organisational waste, systematic error and inappropriate use of TCPs all arise from good policy, management and clinical decisions. If these are based on evidence from research, local data and/or stakeholder views there are sound positive drivers for action. There is no need for the concept of disinvestment to be introduced as a reason for change. | Focus on the positive reasons driving removal, reduction or restriction of current practices Use existing systems, processes, expertise, methods and tools whenever possible |
It has been proposed that disinvestment activities are more likely to be successful if decisions are transparent, integrated into everyday decision-making and central to local planning rather than ad hoc decisions, individuals ‘championing’ causes or standalone projects | |
Disinvestment driven from a positive perspective focusing on optimisation of health care through allocation or reallocation of finite resources for maximum effectiveness and efficiency is more likely to be successful. | |
Existing healthcare improvement paradigms such as Knowledge Translation, Evidence Based Practice, Quality Improvement, System Redesign and Health Economics offer theories, frameworks, methods and tools for decision-making, implementation and evaluation that can be applied to disinvestment. |
Level of detail
Components
Characteristics
Domain | SHARE features |
---|---|
Purpose ▪ descriptive, explanatory or predictive | The framework is primarily descriptive to enable application and allow replication and testing. There are also some explanatory elements addressed in the relationships between components, for example ethical principles underpin all activities, decision-making settings sit within the scaffold of all eight principles, projects follow on from decisions, research is conducted in all aspects. |
Development ▪ deductive or inductive ▪ supporting evidence | Methods used in development were both deductive and inductive. Evidence from research literature and other publications was the primary source. Many of these findings were based on extensive work with stakeholder groups. This was supplemented with experience from the SHARE program. |
Theoretical underpinning ▪ explicit or implicit | No specific theory was used to underpin the framework. |
Conceptual clarity ▪ well-described, coherent language for identification of elements ▪ strengths and weaknesses of theories ▪ potential to stimulate new theoretical developments | Three components are outlined in the framework: Program, Projects and Research. The Program is based on eight principles and nine settings for decision-making. The Projects are outlined in eight main steps. The relationships between them are captured in a diagram. Details of each component and the elements within them are provided in the text and in tables. No specific theories were used so no comparisons are made. There is potential for new theoretical developments if: ▪ specific theories are tested in development and implementation of the components ▪ components are removed or the relationships changed ▪ principles or pre-conditions are varied ▪ the framework is applied for purposes other than resource allocation ▪ the framework is applied in a range of contexts |
Level ▪ individual, team, unit, organisation, policy | The framework was developed for implementation at meso level within the health system eg local network, institution, department, ward or committee. |
Situation ▪ hypothetical, real | The framework represents actual settings and contexts in health service decision-making and implementation of change. However it could also be used for teaching or capacity building through hypothetical classroom discussions or simulation exercises. |
Users ▪ nursing, medical, allied health, policy makers, multidisciplinary | The framework can be used by any decision-makers within the health system. While use of the framework could be initiated by any group, engagement and involvement of all relevant stakeholders is an underlying principle of application. The framework could be used in policy, management or clinical contexts. |
Function ▪ barrier analysis ▪ intervention development ▪ selection of outcome measures ▪ process evaluation | The main function is to establish and maintain systems and processes to make, implement and evaluate decisions regarding resource allocation and research the components involved. The principle of evidence-based implementation requires assessment of barriers and enablers but the framework itself does not specifically facilitate this process other than to prompt users. Details of barriers identified from the literature are contained in the text and tables. The steps within the Project component will facilitate development of an intervention for systematic evidence-based decision-making and implementation of change. Evaluation of process and outcomes is a key element; however selection of variables and outcome measures is not facilitated by the framework per se, other than to prompt users to take an evidence-based approach. Examples of measures proposed by others are included in the text. |
Testable ▪ hypothesis generation ▪ supported by empirical data ▪ suitable for different methodologies | The framework describes principles to underpin robust decision-making, settings and opportunities, implementation of change and evaluation of process and outcomes. A range of hypotheses could be developed for each of these elements and the relationships between them which could be tested in a number of ways using various methodologies. The framework could also be tested beyond the local healthcare level, at national or state/provincial level; or outside the health context in education, community development, social services, etc |
Program
Principles for decision-making
Settings
Decision-making infrastructure
Activity | Example | Routine | Reactive | Proactive | Priority Setting |
---|---|---|---|---|---|
Meeting external requirements | ▪ Addressing legislative, regulatory and accreditation requirements, national and professional standards, etc | ✓ | ✓ | ||
▪ Responding to product alerts and recalls | ✓ | ||||
Setting budgets | ▪ Determining sources of income and items of expenditure | ✓ | ✓ | ||
Spending money | ▪ Introducing new items to funding lists. Examples include, but are not limited to, national health schemes, insurance benefits schedules, institutional lists of permitted TCPs, formularies. | ✓ | ✓ | ✓ | ✓ |
▪ Commissioning health services and programs | ✓ | ✓ | ✓ | ✓ | |
▪ Procuring capital works, plant and equipment | ✓ | ✓ | ✓ | ✓ | |
▪ Purchasing clinical consumables | ✓ | ✓ | ✓ | ✓ | |
▪ Assessing grant and funding applications | ✓ | ✓ | |||
Allocating non-monetary resources | ▪ Allocating people, time, access to facilities, etc | ✓ | ✓ | ✓ | ✓ |
▪ Developing guidance documents, promotional information or educational materials that indirectly allocate resources. Examples include, but are not limited to, peak body recommendations, clinical guidelines, protocols, standard operating procedures, decision support systems, posters, presentations. | ✓ | ✓ | ✓ | ✓ | |
Making strategic and operational decisions | ▪ Developing goals and strategies for Strategic Plans | ✓ | ✓ | ||
▪ Developing outcomes measures and targets for Business Plans | ✓ | ✓ | |||
Using evidence to initiate and/or inform decisions | ▪ Updating existing evidence, undertaking Health Technology Reassessment, etc. | ✓ | ✓ | ✓ | |
▪ Accessing and utilising research evidence, population health data, local health service data, consumer and staff feedback | ✓ | ✓ | ✓ | ✓ | |
Evaluating outcomes of previous decisions and projects | ▪ Monitoring, evaluating and reporting of all newly introduced TCPs to see if they perform as expected, post marketing surveillance | ✓ | |||
▪ Monitoring, evaluating and reporting of purposive or random samples of decisions | ✓ | ✓ | ✓ | ||
▪ Monitoring, evaluating and reporting of purposive or random samples of projects | ✓ | ✓ | ✓ |
Specific initiatives
Individual decision-makers
Prompts and triggers
▪ Approve introduction or continuation of TCPs for limited time only and require review of desired outcomes, costs, etc. before re-approval is granted at end of time period |
▪ Approve new guidelines and protocols for limited time only and require review of evidence, costs, etc. and appropriate revision before re-approval is granted at end of time period |
▪ Include steps that consider disinvestment of existing practices in manuals for guideline and protocol development |
▪ Include steps that consider disinvestment of existing practices in checklists for a range of organisational decisions |
▪ Add consideration of disinvestment to templates for meeting agendas where appropriate |
▪ Mandate consideration of disinvestment in procurement processes: include in requistion documents and require sign off by relevant body overseeing disinvestment at appropriate level |
▪ Systematically ascertain evidence from research, data or stakeholder feedback, send directly to decision-makers and seek and/or require response |
▪ Incorporate flags and/or question use of low value TCPs in clinical decision support systems |
▪ Build questions about potential disinvestment into business case templates and application forms for grants, changes to formulary, introduction of new TCPs, etc. |
▪ Introduce requirements for consideration of disinvestment into documents governing scope of decisions such as position descriptions and committee Terms of Reference |
▪ Add prompts to consider disinvestment to data reports, scorecards, dashboards, etc. |
▪ Add prompts to consider disinvestment in project management templates and training programs for project management, change management, quality improvement processes, etc. |
▪ Build disinvestment into strategic planning processes |
▪ Build disinvestment KPIs into business plans or performance plans |
▪ Consider ‘one for one’ swaps where a new TCP can only be introduced if an old one is removed |
Steps in the disinvestment process
Projects
Research
Methods and tools
-
An investigation of the resource allocation process in a local health service generated a framework of eight components, the relationships between them, and features of structure and practice for each component [6]. Structure is described as ‘who’ and ‘what’ and includes people, systems, policies, requirements, relationships and coordination. Practice addresses ‘how’ through processes, procedures, rules, methods, criteria and customs.
-
A classification of decision-making settings, decision-makers, and scope and type of decisions was developed and strengths, weaknesses, barriers and enablers to resource allocation in a local health service were ascertained [6].
-
A model for exploring Sustainability in Health care by Allocating Resources Effectively (SHARE) in the local healthcare setting brings together systems and processes for decision-making; identifying and undertaking disinvestment projects; support services to facilitate making, implementing and evaluating decisions; evaluation and research to measure and understand the processes and outcomes of these disinvestment-related activities; and principles and preconditions for success and sustainability [8].
1. Identification of opportunities
1.1 Research
1.2 Health service data
1.3 Stakeholder nominations
▪ Discuss principles of disinvestment and examples of successful projects at department/unit meetings, educational events, etc. |
▪ Assign a group member to look for disinvestment opportunities in committee/working party decisions |
▪ Add a disinvestment question to the ‘Leadership Walkround’ protocol |
▪ Identify clinical champions interested in disinvestment in each program/department/unit who would look out for opportunities |
▪ Support staff who have undertaken a disinvestment project to look for more opportunities |
▪ Have disinvestment as a high priority in medication safety reviews |
▪ Encourage or require projects that are introducing something new to have a component of disinvestment |
▪ Review projects that are being conducted for other reasons and identify and focus on any disinvestment elements |
1.4 ‘Low value’ lists
1.5 Economic approaches to priority setting
2. Prioritisation and decision-making
3. Development of a proposal
4. Implementation
5. Monitoring, evaluation and reporting
6. Reinvestment
7. Dissemination and diffusion
8. Maintenance
-
SHARE projects were assessed against a framework for sustainability based on five categories: structure, skills, resources, commitment and leadership [8].
-
The SEAchange model for sustainable, effective, appropriate evidence-based change in health services applied in SHARE projects includes formal assessment of sustainability at each step in the change process [41].
-
The determinants of effectiveness outlined in a framework and taxonomy adapted for evaluation and explication of SHARE disinvestment projects could be considered in developing strategies for sustainability of new disinvestment interventions [9].
-
The preconditions and underlying principles derived from the literature and local research in development of the SHARE model for exploring sustainability in health care by allocating resources effectively in the local health service setting were identified as factors related to success and sustainability of the whole SHARE Program [8].
Barriers and enablers
Common to all aspects of disinvestment ▪ Lack of common terminology, theories, tested frameworks and models, proven methods and tools ▪ The word ‘disinvestment’ generates negativity and mistrust ▪ Divergent understanding of the concept of disinvestment between researchers and health service decision-makers ▪ Lack of guidance and/or successful examples to follow ▪ Lack of resources particularly time, funds and skills ▪ Lack of any of the elements of the framework ▪ Resistance to change |
Establishment and delivery of program ▪ Lack of communication between agencies ▪ Autonomy of agencies resulting in multiple different systems ▪ Wastage of resources by duplication of effort, particularly in HTA ▪ Lack of resources to support policy mechanisms ▪ Lack of appropriate data collection systems ▪ Cost of appropriate data collection systems ▪ Lack of political, clinical, or administrative will to achieve change ▪ Difficulty establishing systems and processes to assess choices and reallocate resources across and between programs. Easier when done within programs but this has limited effectiveness. ▪ Difficulty establishing systems and processes between competing sectors or paradigms eg cure versus prevention, acute versus community care, drug therapy versus counselling ▪ Lack of coordination and integration of systems and processes ▪ Short-termism in government policy ▪ Conflicting priorities – at individual levels, and/or between levels ▪ System inertia ▪ Longstanding structures, institutional practices and organisational relationships ▪ Poor understanding of organisational practices and relationships ▪ Lack of established triggers to initiate disinvestment discussions ▪ Scarcity of strategic plans that include disinvestment ▪ Lack of incentives, presence of disincentives ▪ Fee for service models reward quantity not quality |
Stakeholder engagement ▪ Lack of stakeholder commitment ▪ Stakeholder inertia ▪ Difficulty identifying and engaging multiple diverse stakeholders ▪ Resistance to, or lack of understanding of consumer participation |
Identification of disinvestment opportunities ▪ Health Technology Reassessment (HTR) not conducted routinely ▪ Public and private funding focused on HTA rather than HTR ▪ Insufficient ‘unequivocal’ evidence to disinvest ▪ Lack of mechanisms to identify disinvestment targets ▪ Difficulties in producing, accessing & interpreting economic data ▪ Willingness to use lower quality evidence to maintain status quo |
Prioritisation and decision-making ▪ Lack of knowledge of available tools ▪ Unfamiliarity with economic evaluations ▪ Disagreement with assumptions in economic evaluations ▪ Difficulties estimating marginal costs ▪ Reluctance to disinvest if there are sunk costs in existing technology and supporting capital infrastructure ▪ Reluctance to expend effort in disinvestment if benefits not clear ▪ Gains from disinvestment are less readily measured and may not happen but losses from disinvestment are immediate ▪ Strength of vested interests and lobby groups ▪ Lack of negotiating skills making it difficult to resist opposition ▪ Conflicting priorities between decision-makers ▪ Conflicting priorities between local, regional and national levels ▪ Reluctance to disinvest due to heterogeneity of outcomes and/or if there is potential for benefit in some subgroups or individuals ▪ Controversy associated with removal of an effective TCP in favour of a more cost-effective alternative and/or where there is lack of evidence of effect but general perception that it works ▪ Sensitivity of disinvestment target eg children, cancer, end of life ▪ Lack of decision-making processes ▪ Lack of integration with other decision-making processes ▪ Requirement for prospective data collection or further research to provide enough information for decision ▪ Difficulty making choices and reallocating resources across and between programs. Easier when done within programs but this has limited effectiveness. ▪ Difficulty making choices between competing sectors or paradigms eg cure versus prevention, acute versus community care, drug therapy versus counselling ▪ Decision-makers not held in sufficiently high regard for decisions to be respected and enforced ▪ Perceived influence of power imbalances and hidden agendas ▪ Political challenges |
Implementation ▪ Inadequate project timelines ▪ Lack of funding for implementation ▪ Lack of skills in project management ▪ Lack of skills in change management ▪ Loss of patient choice ▪ Loss of perceived entitlement to treatment ▪ Loss of clinical autonomy ▪ Clinician reluctance to remove practices they perceive as integral to their professional practice and identity ▪ Loss of perceived benefit of intervention being removed ▪ Perceived criticism of practice and/or practitioners ▪ Perception that management priority is only to save money ▪ Lack of incentives, presence of disincentives ▪ Lack of data to substantiate need ▪ Gains from disinvestment less readily measured and may not happen, but losses from disinvestment are immediate ▪ Complexity of practice change if disinvestment limited to certain groups or for certain indications ▪ Lack of coordination between projects resulting in gaps and duplication ▪ Stakeholder fatigue and disillusionment with constant change |
Monitoring and evaluation ▪ Routinely-collected data not valid or reliable, often out-of-date ▪ Routinely-collected data not precise or specific enough ▪ Cost of obtaining appropriate data ▪ Lack of post-market surveillance ▪ Lack of methods to quantify savings ▪ Distrust of reasons for monitoring and evaluation |
Reinvestment ▪ Lack of methods for reallocating resources released ▪ Lack of examples of successful reinvestment ▪ Some cost savings may not be realised eg length of stay reduced but beds immediately filled with other patients of greater acuity |
Research ▪ Assumptions that current practice is effective ▪ Ethical objections to randomising patients to control groups ▪ Resistance to enrolling patients in trials due to belief in intervention ▪ Difficulty getting funding to research existing practices |